Papers

Arizona PCSK9 Report Card – September 2022

Arizona’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Arizonans’ prescriptions for cholesterol-lowering medication.

Oklahoma PCSK9 Report Card – August 2022

Oklahoma’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Oklahomans’ prescriptions for cholesterol-lowering medication.

Texas PCSK9 Report Card – August 2022

Texas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Texans’ prescriptions for cholesterol-lowering medication.

Mississippi PCSK9 Report Card – August 2022

Mississippi’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Mississippians’ prescriptions for cholesterol-lowering medication.

Arkansas PCSK9 Report Card – August 2022

Arkansas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Arkansans’ prescriptions for cholesterol-lowering medication.

Rejected: How Life-Saving Heart Medication Eludes Women, Southerners & People of Color

Every 36 seconds, someone in the United States dies from cardiovascular disease. In fact, heart disease is the leading cause of death in America, responsible for one in every four adult fatalities. Making sure patients can access medication that protects their hearts should be a top national health care priority. But recent insurance claims data […]

Non-Medical Switching and Cardiovascular Health

As Americans come to terms with the more than half a million victims of COVID-19, many overlook a startling fact. Cardiovascular disease exacts an even larger toll on public health every year.

The Unmet Needs of Heart Failure Patients

On November 13, 2020, the Partnership to Advance Cardiovascular Health hosted a virtual town hall meeting to explore the unmet needs of heart failure patients.